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Abstract
Background: In developed countries, the incidence of neonatal hydrocephalus 
ranges from 3 to 5 cases per 1000 live births, but little is known about the frequency 
of hydrocephalus in Africa. In Mozambique, there is no primary information related 
to this disorder, but using the above data, the expected incidence of neonatal 
hydrocephalus would range from 2900 to 4800 cases per year.
Methods: This study is based on 122 children younger than 1 year with neonatal 
hydrocephalus, followed up between January 2010 and December 2012, their 
origin and treatment, and aims to evaluate difficulties with diagnosis, treatment, 
and follow‑up in northern Mozambique.
Results: Identified cases were mainly less than 6 months old (77%), with severe 
macrocephaly and the classic stigmata of this condition. A high rate of follow‑up 
loss (44.3%) was detected, particularly among children from more distant locations. 
Our findings contrast with the expected 1000-1700 cases that would occur in the 
area during the study period, being considerably lower.
Conclusions: Hydrocephalus is a serious problem in sub‑Saharan Africa, 
whose effects can be minimized by a better organization of the health system in 
hydrocephalus prevention, referral, and follow‑up. New management alternatives 
to provide treatment to more children with this disorder and reduction of the 
follow-up difficulties caused due to geographical reasons for the children undergoing 
treatment are essential.
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INTRODUCTION
Since the middle of the last century, hydrocephalus has 
been treated using valve‑regulated ventricular derivations, 
which continue to be widely used.[15] The poor cognitive 
and motor development in children, the loss of the 
cognitive function, and visual loss can complicate 
untreated hydrocephalus and persist after treatment,[3,38] 
with the consequent impairment interfering in their 
development in an important way.
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In developed countries, the incidence of congenital 
hydrocephalus has been estimated at 0.5 cases per 1000 
live births and the incidence of neonatal hydrocephalus 
has been estimated at 3‑5 cases per 1000 live births, with 
a male predominance.[5,45] The incidence distribution is 
bimodal with most hydrocephalus cases occurring among 
children. It is one of the most common developmental 
disorders, surpassing Down’s syndrome or congenital 
deafness.[16] It is, therefore, the most often‑treated 
neurosurgical condition in pediatric practice.[18,21,44]
Although hydrocephalus is reported to be more common 
in developing countries, its prevalence is yet to be 
determined.[18,44] The current incidence of hydrocephalus 
in sub‑Saharan Africa is unknown.[45] In this region, it is 
estimated that less than 10% of cases are annually treated 
using the ventriculoperitoneal shunt (VPS) systems. 
It is known that many children with hydrocephalus in 
sub‑Saharan Africa are not taken to health facilities 
for treatment due to poverty, erroneous cultural 
interpretations about hydrocephalus in children, and 
various other reasons.[45] Most children who suffer from 
this medical condition unfortunately do not even have 
the chance to be treated.[32]
The crude birth rate in Mozambique was 41.6/1000 
in 2011,[26] with a projected population of 23,049,621 
inhabitants,[26] which gives an estimate of 958,864 
births/year. Using data from developed countries 
to estimate incidence, 480 new cases of congenital 
hydrocephalus and from 2900 and up to 4800 new cases 
of neonatal hydrocephalus are predicted each year in 
Mozambique.[45]
Comparing the developing countries (as is the 
case of Mozambique) with developed countries, an 
incidence of congenital hydrocephalus greater than 
or equivalent to that in developed countries would 
be expected, but non‑congenital (acquired) etiologies 
of hydrocephalus in children are expected to be 
different–the post‑hemorrhagic cause associated with 
prematurity being the most common in Western 
countries and post‑infectious hydrocephalus (PIHC) 
being more common in developing countries.[44,45]
It is believed that the increased prevalence in Africa is 
due to an increase in birth rate and, thus, an increase 
in occurrence of congenital abnormalities, as well as 
increased rates of neonatal infections.[18,32,44]
Low socioeconomic status is a risk factor for all non‑genetic 
(acquired) defects, including hydrocephalus.[41]
Non‑genetic structural defects can occur for several 
reasons. Hydrocephalus is strongly associated with spina 
bifida, and this defect is caused by a deficiency of 
folates/folic acid in the maternal diet.[24,30] Multivitamin 
supplements during pregnancy have singly been shown to 
reduce the risk of hydrocephalus.[19,24]
Low maternal age has been associated with a higher risk 
of hydrocephalus, probably because younger mothers do 
not undergo prenatal screening.[36] Maternal age at first 
birth is lower in developing countries than in developed 
countries. In Mozambique, most primigravidae are in the 
age group ranging between 20 and 24 years.[26]
In north Mozambique, prenatal care provided by 
health personnel (doctors, nurses, midwives or auxiliary 
or traditional birth attendants) reaches 90‑96% of 
pregnant women; however, assisted deliveries and 
post‑delivery/neonatal care by skilled health personnel 
remain low throughout the country (54%), ranging from 
35.6% in Cabo Delgado province to 60.3% in Niassa 
province (Nampula province – 55.3%) in the northern 
region. These percentages are directly related to the low 
level of education of pregnant women.[26,27]
The Nampula’s Central Hospital (HCN), a tertiary 
hospital, is the reference facility for the country’s 
northern region, having an estimated population 
of almost 8,000,000 inhabitants (more than one‑third 
of the country’s population), with a crude birth rate of 
41.6/1000 inhabitants (2011).[26,45]
In this study, data were collected regarding the baseline 
clinical presentation and the initial approach to all cases 
of hydrocephalus (122) in patients under the age of 
1 year treated at Nampula’s Central Hospital (HCN), 
from 1 January 2010 to 31 December 2011 and followed 
up until 31 December 2012.
MATERIALS AND METHODS
Between 1 January 2010 and 31 December 2011, 122 
pediatric cases of hydrocephalus, under 1 year of age, were 
treated surgically at Nampula’s Central Hospital (HCN), 
from the provinces of Nampula, Cabo Delgado, and 
Niassa, of a total of 152 cases of operated hydrocephalus 
(724 neurosurgical procedures were performed during the 
same period).
The follow‑up period was until 31 December 2012.
We included all cases of hydrocephalus patients younger 
than a year of age, submitted to surgery, who were 
referred to the Nampula’s Central Hospital (HCN) and 
came from the catchment area of the hospital, i.e. the 
provinces of Nampula, Cabo Delgado, and Niassa. The 
diagnosis was clinically based (signs of macrocephaly 
and intracranial hypertension) and confirmed by 
cranioencephalic computed tomography (CT). A referral 
network exists from primary health centers, to rural, 
provincial, and finally central‑level hospitals, and some 
patients have to travel nearly 700 km to have access to 
the care of a neurosurgeon.
The provisional diagnosis is made clinically by the 
healthcare professional who observes the patient (at the 
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health center or rural hospital) and the child is sent 
to the provincial referral hospital. After evaluation at 
the provincial referral hospital, the child is remitted 
for evaluation by a neurosurgeon who, with the current 
clinical and CT information, establishes the diagnosis 
and defines the treatment plan.
During the data collection period, only one neurosurgeon 
was active at the Nampula’s Central Hospital (HCN).
Data were collected by the above‑mentioned 
neurosurgeon, assisted by a graduate student of medicine, 
by completing a specific protocol for this purpose – after 
the parents or guardians of the children signed an 
informed consent.
Six HIV‑infected and malnourished infants were admitted 
with hydrocephalus, but excluded from this study, as they 
presented gravely ill and were not able to be stabilized 
for anethesia and surgical intervention. All six of these 
patients died.
For the cephalic perimeter assessment, performed by the 
same neurosurgeon, standard WHO head circumference 
by age Z score tables were used.[49]
The Alberta Infant Motor Scales (AIMS) tool was used 
for the evaluation of psychomotor development, and the 
results were grouped or summarized into four groups 
(appropriate, slight mental retardation, moderate mental 
retardation, and severe mental retardation).
The data were entered and analyzed with the software 
program IBM SPSS Statistics, version 20.0.
RESULTS
We calculated the expected number of cases 
corresponding to the 2‑year period of this study. To 
do this, the official projections for the population 
by province, the crude birth rate, and the incidence 
rate of neonatal hydrocephalus in the developed 
world were used, since at present there is no data 
on the incidence of hydrocephalus in sub‑Saharan 
Africa.[45] With this methodology, Mozambique is 
expected to have between 2900‑4800 new cases of 
pediatric hydrocephalus each year, with 1000‑1700 (in 
a conservative perspective) of those coming from the 
Northern region of the country.
For northern Mozambique, the expected incidence of 
neonatal hydrocephalus cases between 2010 and 2011 is 
shown in Table 1, and in summary only about 15% of 
the expected cases were referred. However, there was no 
statistically significant difference between the expected 
cases and the cases diagnosed/referred (P = 0.200; 
Chi square), when different provinces were compared 
with each other.
Among the cases referred to the Nampula’s Central 
Hospital (HCN), 8% came from the city of Nampula, 
53% from Nampula province (average distance 350 km), 
29% from the province of Cabo Delgado (405 km from 
the province capital – Pemba), and 10% from Niassa 
province (695 km from the province capital – Lichinga).
There was no gender predominance (sex ratio 1:1) and 
77% were younger than 6 months. Distribution by age is 
shown in Figure 1.
Macrocephaly was present in all children (reason for 
referral), with 77% infants having above the 95th percentile 
of cephalic perimeter, 16.4% between 95th and 90th 
percentile, and 6.6% between 90th and 75th percentile. The 
anterior fontanelle was taut without bulging in 56.7% of 
patients, bulging and slightly depressible in 28.3%, bulging 
and not depressible in 6.7%, and without bulging and 
depressible in 8.3%. Sunset eye sign were present in 47.5%.
Psychomotor development was adequate in 45.9%, 39.3% 
presented a slight retardation, 12.3% with a moderate 
retardation and 2.5% had a severe retardation.
All cases underwent surgical treatment, which consisted 
in setting in place a VPS system. The National Health 
System in Mozambique currently offers the Chhabra 
Surgywear® valve system; however, in 8% of cases, the 
non‑valved Harare type system had to be used because of 
rupture of the stock.
The duration of postoperative hospitalization for 
cases without immediate surgical complications was, 
on average, 8 days, and for those cases with any 
post‑operative complication was 26.4 days (minimum 
13 days, maximum 68 days).
Table 1: Expected incidence and referred cases of neonatal hydrocephalus during a period of 2 years in northern 
Mozambique (2010-2011)
Est*. 
population[21, 22] (2011)
Est*. births[21, 22] 
(2010+2011)
EI** 
(2 years)
RC (n)*** 
(2 years)
RC (%)****
Mozambique 23,049,621 1,796,086 5,388-8,980
Northern provinces 7,977,134 652,549 1,957-3,263 122 11.0-18.3
Nampula 4,647,841 381,790 1,145-1,909 71 3.7-6.2
Cabo delgado 1,797,335 148,159 444-741 39 5.3-8.8
Niassa 1,531,958 122,600 368-613 12 2.0-3.3
*Estimated, **Expected incidence, ***Referred cases (n), ****Percentage of referred cases (%) in relation to expected incidence
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Global complication rate was 5.7% – three cases of 
obstruction of the ventricular system, one migration of 
the ventricular catheter, one migration of the abdominal 
catheter, one ventriculitis, and one peritonitis.
During the study period (36 months), the follow‑up loss 
was 44.3% (54 patients): 1 patient in the city of Nampula 
(representing 10% of the patients coming from this 
location), 20 patients in Nampula province (representing 
about 30% of the patients coming from this location), 
and more than 70% patients lost to follow‑up from the 
provinces of Cabo Delgado and Niassa (33 patients).
At follow‑up (56%), between 13 and 34 months (average 
22.4 months), all patients had a functioning system.
DISCUSSION
The natural history of hydrocephalus leads to severe 
neurological deficits associated with major morbidity, 
causing sufferers of this condition to be totally dependent 
in their daily lives and in need of closer medical 
follow‑up, which leads to a large social and economic 
impact on families.[9] Appropriate and timely treatment 
can reduce this impact.[40]
Hydrocephalus has been known since 1811 when 
Cooke reported a case.[8] Since then, definition, 
etiology, symptoms, classification, and treatment 
options are debated more often, and there are (on 
Pubmed database) more than 27,000 articles related 
to the issue. In Africa, the first article related to 
hydrocephalus was published by Clifford in 1963.
[7] and 20 years later and important case series on 
hydrocephalus in Africa was published by Peacock and 
Currer.[31] Less than 1% of articles about hydrocephalus, 
indexed to Pubmed are related to Africa. The care 
of hydrocephalus in sub‑Saharan Africa is hampered 
by economic constraints (poverty), difficulties for 
patients and families in securing transportation means 
and access to adequate care, and cultural mistakes/
misunderstandings related to hydrocephalus.[23,45] 
There is no epidemiological data on hydrocephalus in 
Mozambique. Cerebrospinal fluid (CSF) shunt systems, 
as well as neurosurgeons able to set them in place, are 
not available for most children and, when available, 
most people are not able to acquire a VPS system. This 
paper is the basis for a more exhaustive study in future 
and seeks to contribute to the improvement of care of 
hydrocephalus in Mozambique.
The diagnosis of hydrocephalus is clearly underestimated 
in northern Mozambique, probably because personnel 
not trained to diagnose hydrocephalus perform deliveries 
and neonatal care. Moreover, neonatal care only reaches 
half of the pregnant women in northern Mozambique 
(50.4%),[26,27] which further implies a reduced capacity 
of diagnosis of neonatal hydrocephalus (50%). As shown 
in Table 1, only 20% of expected cases are referred for 
neurosurgeon evaluation.
Patients referred to the Nampula’s Central Hospital 
(HCN) arrive there with evolved forms and severe 
hydrocephalus stigmata – more than 90% with a 
cranial perimeter above the 90th percentile and taut 
fontanelle, 15% with a significantly retarded psychomotor 
development, and more than 50% with some degree of 
impairment. These evolved forms can be avoided by early 
diagnosis and timely treatment.
There is, therefore, a crucial need to train health 
personnel from the most basic care units for pregnant 
women and newborn to the care units for the general 
population in order to ensure early diagnosis and timely 
referral.
Most infants presented obstructive hydrocephalus 
(98.4%). This diagnosis was confirmed only with the 
use of cranioencephalic CT, since there is no magnetic 
resonance image (MRI) apparatus at Nampula’s Central 
Hospital (HCN). The main causes are presented in 
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Figure 1: Distribution by age (in months)
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Figure 2: Etiology of hydrocephalus
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In Africa, post‑infectious etiology varies from 7%[4,31] 
to 60%,[44] and is correlated to the level of health of 
the considered population.[4] The ratio of congenital 
to “post‑meningitic” hydrocephalus in Zimbabwe 
(a neighbor country) was reported to be 2:1.[1,44] PIHC 
represents one‑third of this series and has therefore been 
included in reported literature.
Although the methods of choice for the study 
of hydrocephalus are MRI and CT,[11,29,33] the 
transfontanellar ultrasound plays an important role in 
the diagnosis and characterization of brain lesions in 
the newborn (e.g. hemorrhage, ventricular dilatation, 
leukomalacia, malformations, etc.). For its safety and ease 
of implementation and for the possibility of serial exams 
to assess the evolution of brain lesions, transfontanellar 
ultrasound is considered a method of choice in the 
evaluation of the newborn at risk, being even, in most 
cases, the only method needed.[10,12] In Mozambique, 
this resource is not routinely used and it should be 
considered, since it is painless, relative easy to perform, 
more readily available than MRI and CT, and provides 
valuable clinical information. Capacitating Mozambican 
health care workers to perform this type of ultrasound 
examination is a priority.
Even with higher rates of major complications, VPS 
remains the primary treatment option in the orientation 
of hydrocephalus. The complication rates range between 
1% and 50% by 2 years after surgery,[13,14,18,42,45,48] including 
failures of the systems and infections.[18,22,28,42,45] Until 
recently, VPS systems used in Mozambique were of the 
simple type,[25] consisting of a silicone tube, reported in 
Zimbabwe and Malawi series.[2,20] Those were rudimentary 
systems without a valve regulation and with inherent 
higher risks and complications. Currently, the Chhabra 
Surgywear systems, manufactured in India, are in use, 
and costing the Mozambican Health System about $100 
USD/unit. It is noteworthy that 89% of the complications 
occurred in Harare shunts and 11% in Chhabra. All cases 
underwent further surgery to remove the dysfunctional 
system and for installing a Chhabra Surgywear valve 
system. The ideal VPS system does not exist[34] and the 
availability of each system has been a major limiting factor, 
rather than the surgeon’s preference.[34] Chhabra Surgywear 
VPS systems (now routinely used in Mozambique) have 
similar complication rates to systems used in the Western 
countries, without statistically significant differences in 
complications, as reported in a study in Uganda.[42]
Operations took place in most of the cases within an 
acceptable time frame, given the logistic conditions. 
Surgeries that took place between 1 and 2 weeks after 
evaluation by a neurosurgeon were due mostly to lack 
of surgical time. In cases presenting with co‑morbidities 
including respiratory and gastrointestinal infections, and 
malaria, surgery was delayed for 2 weeks. However, the 
diagnosis was late because most of the children presented 
severe stigmata of the clinical condition, which could be 
minimized by early diagnosis and referral.
In this series, only seven cases of complications related 
to the surgical procedure were reported (5.7%). The 
follow‑up loss is considerable and it certainly affects this 
value, making the complication rate inconsiderable. Of 
course, a new healthcare orientation on hydrocephalus 
in Mozambique is of utmost importance to overcome 
this local difficulty. In the series of sub‑Saharan Africa, 
the described complications vary between 7% and 
69% and are related to mechanical causes (obstruction 
and VPS system migration) (11‑54%) and infection 
(7‑69%).[4,28,31,35,37,39,40,44] Even when the VPS placement 
is possible, it is more dangerous in the African context 
than in developed countries because of the infectious 
complications and shunt’s malfunctioning.[42] Infectious 
complications of VPS implantation can be reduced by 
implementing protocols that train staff in infection 
control measures related to the preoperative, operative, 
and postoperative period, as reported by Choux 
et al.,[6] being fundamental to adapt this knowledge to 
local reality. The follow‑up losses are proportional to 
the distance of patients’ residences from the Nampula’s 
Central Hospital (HCN). The economic difficulties 
related to extreme poverty, poor road infrastructure, 
and long distances are challenging constraints for the 
appropriate follow‑up of these children.
A large number of children may alternatively benefit 
from endoscopic third ventriculostomy (ETV), which is 
a treatment option, without heterologous material, with 
a long‑term lower rate of associated complications[17,23,39,43] 
and with a follow‑up that we believe can be less frequent, 
thus reducing the socioeconomic impact on the families 
of these patients.[46,47]
The average cost of this equipment is around $50,000 
USD,[25] with investment recovered after about 
500 procedures, without including shorter periods 
of hospitalization, reduced need for hospital visits 
for follow‑up, fewer complications, and its strong 
socioeconomic impact on families,[46,47] as reported on 
ETV procedures.
CONCLUSIONS
Hydrocephalus in sub‑Saharan Africa is a serious health 
problem. Although more investigation and publishing is 
increasingly being carried out, there is still little data on 
its incidence, prevalence, and causes.
To improve the quality of care of patients with 
hydrocephalus in a country with a social, economic, and 
cultural context, such as Mozambique, is a challenge that 
goes far beyond the aspect of neurosurgical treatment.
Surgical Neurology International 2014, 5:175 http://www.surgicalneurologyint.com/content/5/1/175
In northern Mozambique, like in the rest of the country, 
and in sub‑Saharan Africa, there is an urgent need 
for strategies to address a medical condition that has 
devastating consequences when left untreated.
In addition to appropriate assistance during pregnancy 
and delivery, early diagnosis and appropriate orientation 
are essential.
Measures including folic acid supplementation for the 
prevention of neural tube defects, improved follow‑up 
of pregnant women, improved public educations, 
improvement and capacity development in health 
centers, particularly in peripheral areas, can help improve 
early diagnosis, retention in care, and patient follow‑up.
Due to the simplicity and lower price of the exam 
(compared with MRI and CT), the transfontanellar 
ultrasound should be considered for diagnosis in 
Mozambique.
There is a need to implement viable therapeutic options, 
such as ETV, which have lower costs for the health system 
in the short and medium term, giving the best result for 
the patient and having lower socioeconomic impact on 
the families of patients.
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